Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach?-Reference-Cited by-同舟云学术

Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach?

Published:2021-03-04 Issue:2 Volume:5 Page:285-298
ISSN:2509-4262
Container-title:PharmacoEconomics - Open
language:en
Short-container-title:PharmacoEconomics Open

Author:

Pruneri Giancarlo,De Braud Filippo,Sapino Anna,Aglietta Massimo,Vecchione Andrea,Giusti Raffaele,Marchiò Caterina,Scarpino Stefania,Baggi Anna^ORCID,Bonetti Giuseppe,Franzini Jean Marie,Volpe Marco,Jommi Claudio^ORCID

Funder

Roche Italia

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Health Policy,Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s41669-020-00249-0.pdf

Reference29 articles.

1. Vrijenhoek T, Kraaijeveld K, Elferink M, et al. Next-generation sequencing-based genome diagnostics across clinical genetics centers: implementation choices and their effects. Eur J Hum Genet. 2015;23(9):1142–50.

2. Zhao X, Wang A, Walter V, et al. Combined targeted DNA sequencing in non-small cell lung cancer (NSCLC) using UNCseq and NGScopy, and RNA sequencing using UNCqeR for the detection of genetic aberrations in NSCLC. PLoS ONE. 2015;10(6):e0129280.

3. Torshizi AD, Wang K. Next-generation sequencing in drug development: target identification and genetically stratified clinical trials. Drug Discov Today. 2018;23(10):1776–83.

4. Phillips KA, Deverka PA, Marshall DA. Methodological issues in assessing the economic value of next-generation sequencing tests: many challenges and not enough solutions. Value Health. 2018;21(9):1033–42.

5. Fahr P, Buchanan J, Wordsworth S. a review of health economic studies comparing traditional and massively parallel sequencing diagnostic pathways for suspected genetic disorders. Pharmacoeconomics. 2020;38:143–58.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Approach in Oncology and Policy Implications: A Literature Review;Value in Health;2024-09

2. Implications of genetic testing and informed consent before and after genetic testing in individuals with cancer;World Journal of Clinical Oncology;2024-08-24

3. Next-generation sequencing in oncology: challenges in economic evaluations;Expert Review of Pharmacoeconomics & Outcomes Research;2024-08-11

4. Limitations of current techniques in clinical antimicrobial resistance diagnosis: examples and future prospects;npj Antimicrobials and Resistance;2024-06-17

5. Enhancing the epidemiological surveillance of SARS-CoV-2 using Sanger sequencing to identify circulating variants and recombinants;Brazilian Journal of Microbiology;2024-05-28